Last reviewed · How we verify

NCT07181317: WAMIF-suivi

WAMIF: Prospective Study in Young Women Presenting Acute Myocardial Infarction: Cohort Follow up

Recruiting now Last updated 12 January 2026
What this trial tests

trial testing Questionnaires in Myocardial Infarction, Acute in 314 participants. Currently enrolling.

Timeline
25 November 2025
Primary endpoint
30 September 2029
30 September 2029

Quick facts

Lead sponsorFrench Cardiology Society
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment314
Start date25 November 2025
Primary completion30 September 2029
Estimated completion30 September 2029
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

French Cardiology Society

Who can join

Adults 18 to 60, female only, with Myocardial Infarction, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The WAMIF study was conducted from 2017 to 2019, including 314 patients in 30 French research centers spread across metropolitan France. It systematically collected the clinical, morphological, and biological characteristics of myocardial infarction cases affecting women under 50 years of age and assessed their short-term (in-hospital) and medium-term (12-month) prognosis. Extending the follow-up beyond 12 months for this first study would provide fundamental data for understanding and improving the care of these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Myocardial Infarction, Acute

Currently open trials in the same condition.

Other French Cardiology Society trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07181317.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing